For the Inventor, By the Inventor

Enter inventor name

Mountain View, CA, United States of America

James W Larrick

USPTO Granted Patents = 56 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 3.0

ph-index = 12

Forward Citations = 426(Granted Patents)

Forward Citations (Not Self Cited) = 329(Dec 10, 2025)

Location History:

Mountain View, CA (US) (2010 - 2014)
Woodside, CA (US) (1986 - 2021)
Sunnyvale, CA (US) (2011 - 2024)

Company Filing History:

Menlo Therapeutics Inc.

Panorama Research Inc.

Cetus Corporation

Neuromolecular, Inc.

Larix Bioscience LLC

Braasch Biotech LLC

Tigercat Pharma, Inc.

8. 3 out of 5,309

Leland Stanford Junior University

9. 2 out of 656

Chiron Corporation

10. 2 out of 16

Celonova Biosciences, Inc.

Transtarget, Inc.

12. 1 out of 15,475

University of California

Planet Biotechnology Inc.

Cetus Onocology Corporation

15. 1 out of 29

Adamas Pharmaceuticals, Inc.

Nepenthe Bioscience LLC

Vyne Therapeutics Inc.

Cts Biopharma LLC

19. 3 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

Loading Chart...

Areas of Expertise:

CNS Disorders

Aminoadamantyl Nitrate Compounds

NK-1 Receptor Antagonists

Cell Line Screening

Double Allele Knock Outs

Tissue Repair

Restenosis Prevention

Somatostatin Immunogenicity

Chimeric ICAM-1 Molecule

Antioxidant Nitroxides

Staphylococcal Infections

Human Monoclonal Antibodies

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071392 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2024-08-27),

2. 11447442 - Aminoadamantyl nitrate compounds and their use to treat CNS disorders (2022-09-20),

3. 11161800 - Amantadine nitrate compounds for use as medicaments for the treatment of diseases (2021-11-02),

4. 11078276 - Anti-CD79 antibodies and their uses (2021-08-03),

5. 11060083 - Methods and compositions for producing double allele knock outs (2021-07-13),

6. 11026920 - Use of NK-1 receptor antagonist serlopitant in pruritus (2021-06-08),

7. 10816548 - Cell line screening method (2020-10-27),

8. 10702499 - Use of NK-1 receptor antagonists in pruritus (2020-07-07),

9. 10654925 - Anti-marinobufagenin antibodies and uses thereof (2020-05-19),

10. 10617671 - Use of NK-1 receptor antagonist serlopitant in pruritus (2020-04-14),

11. 10278953 - Use of NK-1 receptor antagonist serlopitant in pruritus (2019-05-07),

12. 10278952 - Use of NK-1 receptor antagonists in pruritus (2019-05-07),

13. 10214478 - Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereof (2019-02-26),

14. 9974769 - Use of NK-1 receptor antagonist serlopitant in pruritus (2018-05-22),

15. 9968588 - Use of NK-1 receptor antagonists in pruritus (2018-05-15),

Title: The Innovative Journey of James W Larrick

Introduction: James W Larrick is a renowned inventor based in Mountain View, CA, known for his groundbreaking contributions to the field of technology and healthcare.

Latest Patents: James W Larrick holds several patents in the areas of biotechnology, medical devices, and software applications, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, James W Larrick has worked tirelessly to develop cutting-edge solutions that have revolutionized the industry. His commitment to innovation has led to the creation of several groundbreaking technologies that have had a significant impact on various sectors.

Collaborations: Throughout his career, James W Larrick has collaborated with leading researchers, scientists, and industry experts to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: James W Larrick's passion for innovation and his dedication to pushing the boundaries of what is possible have established him as a key figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators and inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…